Media Summary: Emmanuel S. Antonarakis, MBBCh, an associate professor of oncology at Johns Hopkins Medicine, discussed updated National ... Adam M. Brufsky, MD, PhD; Harold J. Burstein, MD, PhD; and Claudine Isaacs, MD, clarify the Emmanuel S. Antonarakis, MD, associate professor of oncology, John Hopkins University, discusses the updates from the

Nccn Guidelines For Genetic Testing - Detailed Analysis & Overview

Emmanuel S. Antonarakis, MBBCh, an associate professor of oncology at Johns Hopkins Medicine, discussed updated National ... Adam M. Brufsky, MD, PhD; Harold J. Burstein, MD, PhD; and Claudine Isaacs, MD, clarify the Emmanuel S. Antonarakis, MD, associate professor of oncology, John Hopkins University, discusses the updates from the Experts in colorectal cancer explore the use of genomic James L. Mohler, MD, discusses the rationale and development of the 2019 In this empowering video, we dive deep into the National Comprehensive Cancer Network (

J. Kellogg Parsons, MD, MHS, discusses the rationale behind the National Comprehensive Cancer Network ( Join host Alisyn Camerota as she welcomes Jessica Everett, MS, CGC, Senior Research Strategy Director at UC San Diego's ... William J. Gradishar, MD, chief of hematology and oncology, department of medicine, Betsy Bramsen Professorship of Breast ...

Photo Gallery

NCCN Guidelines for Genetic Testing in Prostate Cancer
Genetic Testing for Prostate Cancer | NCCN Guidelines
Breast Cancer Risks: Guidelines for Genetic Testing
Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer
Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC
Current NCCN Recommendations for Prostate Cancer Genetic Testing
“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”
NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)
What are the NCCN guidelines?
Understanding Genetic Testing
Sponsored
Sponsored
View Detailed Profile
NCCN Guidelines for Genetic Testing in Prostate Cancer

NCCN Guidelines for Genetic Testing in Prostate Cancer

Emmanuel S. Antonarakis, MBBCh, an associate professor of oncology at Johns Hopkins Medicine, discussed updated National ...

Genetic Testing for Prostate Cancer | NCCN Guidelines

Genetic Testing for Prostate Cancer | NCCN Guidelines

Genetic testing

Sponsored
Breast Cancer Risks: Guidelines for Genetic Testing

Breast Cancer Risks: Guidelines for Genetic Testing

Adam M. Brufsky, MD, PhD; Harold J. Burstein, MD, PhD; and Claudine Isaacs, MD, clarify the

Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer

Reviewing NCCN Recommendations for Genetic Testing in Prostate Cancer

Emmanuel S. Antonarakis, MD, associate professor of oncology, John Hopkins University, discusses the updates from the

Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC

Case 1: Genomic Testing & NCCN Guidelines for Metastatic CRC

Experts in colorectal cancer explore the use of genomic

Sponsored
Current NCCN Recommendations for Prostate Cancer Genetic Testing

Current NCCN Recommendations for Prostate Cancer Genetic Testing

James L. Mohler, MD, discusses the rationale and development of the 2019

“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”

“Using NCCN Guidelines in Cancer Management: A Practical Guide for Medical Students”

In this empowering video, we dive deep into the National Comprehensive Cancer Network (

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 1.2026)

Excerpt from the July 2025 ICARE

Prostate Cancer Screening & Genetic Testing: The NCCN Perspective

Prostate Cancer Screening & Genetic Testing: The NCCN Perspective

J. Kellogg Parsons, MD, MHS, discusses the rationale behind the National Comprehensive Cancer Network (

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, & Prostate (Version 2.2026)

Excerpt from the November 2025 ICARE

What are the NCCN guidelines?

What are the NCCN guidelines?

The

Understanding Genetic Testing

Understanding Genetic Testing

Join host Alisyn Camerota as she welcomes Jessica Everett, MS, CGC, Senior Research Strategy Director at UC San Diego's ...

NCCN Guidelines on Molecular Assays for Patients With Breast Cancer

NCCN Guidelines on Molecular Assays for Patients With Breast Cancer

William J. Gradishar, MD, chief of hematology and oncology, department of medicine, Betsy Bramsen Professorship of Breast ...